| Literature DB >> 27176226 |
Gaël Chambonnier1, Lorène Roux1, David Redelberger1, Firas Fadel1,2, Alain Filloux1, Melissa Sivaneson1, Sophie de Bentzmann1, Christophe Bordi1.
Abstract
In response to environmental changes, Pseudomonas aeruginosa is able to switch from a planktonic (free swimming) to a sessile (biofilm) lifestyle. The two-component system (TCS) GacS/GacA activates the production of two small non-coding RNAs, RsmY and RsmZ, but four histidine kinases (HKs), RetS, GacS, LadS and PA1611, are instrumental in this process. RetS hybrid HK blocks GacS unorthodox HK autophosphorylation through the formation of a heterodimer. PA1611 hybrid HK, which is structurally related to GacS, interacts with RetS in P. aeruginosa in a very similar manner to GacS. LadS hybrid HK phenotypically antagonizes the function of RetS by a mechanism that has never been investigated. The four sensors are found in most Pseudomonas species but their characteristics and mode of signaling may differ from one species to another. Here, we demonstrated in P. aeruginosa that LadS controls both rsmY and rsmZ gene expression and that this regulation occurs through the GacS/GacA TCS. We additionally evidenced that in contrast to RetS, LadS signals through GacS/GacA without forming heterodimers, either with GacS or with RetS. Instead, we demonstrated that LadS is involved in a genuine phosphorelay, which requires both transmitter and receiver LadS domains. LadS signaling ultimately requires the alternative histidine-phosphotransfer domain of GacS, which is here used as an Hpt relay by the hybrid kinase. LadS HK thus forms, with the GacS/GacA TCS, a multicomponent signal transduction system with an original phosphorelay cascade, i.e. H1LadS→D1LadS→H2GacS→D2GacA. This highlights an original strategy in which a unique output, i.e. the modulation of sRNA levels, is controlled by a complex multi-sensing network to fine-tune an adapted biofilm and virulence response.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27176226 PMCID: PMC4866733 DOI: 10.1371/journal.pgen.1006032
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Fig 1The GacSA-RetS-PA1611-LadS signaling network.
(A) Current model for the regulatory elements influencing the expression of two sRNAs, RsmY and RsmZ. See text for details. (B) The multicomponent signal transduction system made of the LadS hybrid HK and the GacS/GacA TCS. In the presented model sustained by results obtained in the present study, this multicomponent signal transduction system made of the LadS hybrid HK and the GacS/GacA TCS forms a multiple-input system probably reflecting the variability of environmental conditions P. aeruginosa is faced with and may result in a range of gradations of chronic infection. IM (Inner Membrane), P (Periplasm), C (Cytoplasm).
Fig 2Biofilm production, Pel EPS expression, H1-T6SS production and T3SS expression in the LadS signaling pathway.
The pBBRladS plasmid containing the ladS HK gene (dark bars) and the pBBRMCS4 corresponding empty cloning vector (light bars) were conjugated in the PAK, PAKΔrsmY, PAKΔrsmZ or PAKΔrsmYΔrsmZ strains. (A) Biofilm production in glass tubes was illustrated (upper panel) and quantified after Crystal Violet-staining (lower panel). Corresponding levels of biofilm production represent mean values and standard deviations obtained from three independent experiments. (B) Activity of the pelA–lacZ transcriptional chromosomal fusion was monitored in the same strains with the pBBRladS plasmid containing the ladS HK gene (dark violet bars) and the pBBRMCS4 corresponding empty cloning vector (light violet bars) after 4 hours of growth (OD600nm≈3.5). Corresponding β-galactosidase activities are expressed in Miller units and correspond to mean values (with error bars) obtained from three independent experiments. (C) Production of the H1-T6SS VgrG1s proteins was detected in whole cell extracts using western blot with an anti-VgrG1 polyclonal antibody. Numbers on the left side correspond to molecular weight standards (kDa). (D) Activity of the exoS–lacZ transcriptional chromosomal fusion was monitored in the same strains with the pBBRladS plasmid containing the ladS HK gene (dark royal blue bars) and the pBBRMCS4 corresponding empty cloning vector (light royal blue bars) after 6 hours of growth (OD600nm≈4). Corresponding β-galactosidase activities are expressed in Miller units and correspond to mean values (with error bars) obtained from three independent experiments. Wilcoxon-Mann-Whitney tests were performed and *, **, *** and ns referred to p<0.05, p<0.01 and p<0.001 and nonsignificant difference, respectively.
Fig 3Role of the GacS/GacA TCS in the LadS signaling pathway.
The pBBRladS plasmid containing the ladS HK gene (dark bars) and the pBBRMCS4 corresponding empty cloning vector (light bars) were conjugated in the PAK, PAKΔgacS or PAKΔgacA strains. (A) Activities of the rsmY–lacZ (left panel, blue bars) and rsmZ–lacZ (right panel, brick-red-colored bars) transcriptional chromosomal fusions were monitored after 6 hours of growth (OD600nm≈4) and corresponding β-galactosidase activities are expressed in Miller units and correspond to mean values (with error bars) obtained from three independent experiments. (B) Biofilm production in glass tubes was illustrated (upper panel) and quantified after crystal violet-staining (lower panel). Corresponding levels of biofilm production represent mean values and standard deviations obtained from three independent experiments. Wilcoxon-Mann-Whitney tests were performed and *, **, *** and ns referred to p<0.05, p<0.01 and p<0.001 and nonsignificant difference, respectively. (C) Transcript levels of PelA (violet bars), VgrG1b (T6SS) (green bars) and ExoS (T3SS) (royal blue bars) were monitored by RT-qPCR in PAK, PAKΔgacS and PAKΔgacA strains with the pBBRladS plasmid containing the ladS HK gene and the pBBRMCS4 corresponding empty cloning vector and fold induction was presented for the two mutant strains as compared to the PAK strain. Moderated t-tests were performed; *, ** and *** referred respectively to p<0.05, p<0.01 and p<0.001.
Fig 4Interactions between H1 domains of the LadS hybrid HK, the GacS unorthodox HK and the RetS hybrid HK using pull-down and two-hybrid experiments.
(A) Pull-down experiments. N-terminal FLAG or Strep versions of the H1 domain of GacS, LadS and RetS HKs were constructed in pBBRMCS3 and pCR2.1 vectors, respectively, and expressed in E. coli. Cell lysates were immunoprecipitated using anti-Strep antibody-coupled beads, and FLAG and Strep derivatives were further detected using StrepTactin Alkaline Phosphatase conjugate (upper panel) and anti-FLAG antibody detection (lower panel). (B) In two-hybrid experiments, the ladSH1, retSH1 and gacSH1 DNA regions were cloned into the two-hybrid pUT18C or pKT25 vectors and corresponding vectors were co-transformed in BTH101 cells that were further streaked on LB plates containing X-gal. A blue color of colonies reflects interaction between chimeric proteins, while white color attests to the absence of interaction. The interactions were further quantified by measuring the corresponding ß-galactosidase levels expressed in Miller units (values and standard deviations of 3 independent clones below corresponding colonies).
Fig 5H1 and D1 domain involvement of the LadS hybrid HK in the LadS signaling pathway.
(A) The pBBRladSH1D1 plasmid containing the ladSH1D1 cytoplasmic DNA region of the LadS hybrid HK fused to a C-terminal His-tag, the pBBRladSH1D1 and pBBRladSH1D1 variant plasmids and the pBBRMCS4 corresponding empty cloning vector were conjugated in the PAK strain. Production of the corresponding cytoplasmic versions of LadS was checked in whole cell extracts using western blot and a monoclonal anti-His antibody. Numbers on the left side are molecular weight standards (kDa) (upper panel). Activity of the rsmY–lacZ (blue bars) and rsmY–lacZ (brick-red-colored bars) transcriptional chromosomal fusions were monitored after 6 hours of growth (OD600nm≈4) and corresponding β-galactosidase activities are expressed in Miller units and correspond to mean values (with error bars) obtained from three independent experiments. Wilcoxon-Mann-Whitney tests were performed and *, **, *** and ns referred to p<0.05, p<0.01 and p<0.001 and nonsignificant difference, respectively (middle panel). Production of the H1-T6SS VgrG1 protein was detected in whole cell extracts using western blot with an anti-VgrG1 polyclonal antibody. Numbers on the left side are molecular weight standards (kDa) (lower panel). (B) Biofilm production in glass tubes of PAK, PAKΔladS and of point chromosomal mutants PAKladSH1D1 and PAKladSH1D1 was presented (upper panel) and quantified after crystal violet-staining and extraction (lower panel). Corresponding levels of biofilm production represented by mean values and standard deviations were obtained from three independent experiments. Wilcoxon-Mann-Whitney tests were performed and *, **, *** and ns referred to p<0.05, p<0.01 and p<0.001 and nonsignificant difference, respectively. (C) Transcript levels of RsmY (blue bars), RsmZ (brick-red-colored bars), VgrG1b (T6SS) (green bars) and ExoS (T3SS) (royal blue bars) were monitored in PAK, PAKΔladS and in point chromosomal mutants PAKladSH1D1 and PAKladSH1D1 strains using RT-qPCR. Fold induction was presented for the three mutant strains as compared to the PAK strain. Moderated t-tests were performed; *, ** and *** referred respectively to p<0.05, p<0.01 and p<0.001. (D) Activity of the pelA–lacZ (violet bars) transcriptional chromosomal fusion was monitored after 6 hours of growth (OD600nm≈5) and corresponding β-galactosidase activities are expressed in Miller units and correspond to mean values (with error bars) obtained from three independent experiments. Statistical tests were performed and ** referred to p<0.01.
Fig 6Involvement of the H2 domain of the GacS unorthodox HK in the LadS signaling pathway.
The pBBRladS plasmid containing the ladS HK gene and the pBBRMCS4 corresponding empty cloning vector were conjugated in the PAKΔgacS strain in which the gacSH2 or gacSH2 gene versions or the corresponding suicide vector were chromosomally integrated at the Tn7 site. (A) RsmY (blue bars) and RsmZ (brick-red-colored bars) transcript levels were monitored using RT-qPCR and fold induction was presented in the strains PAKΔgacS::miniTn7gacSH2 (gacSH2) and PAKΔgacS::miniTn7gacSH2 (gacSH2) as compared to the PAKΔgacS::miniTn7 strain (miniTn7). (B) Biofilm production in glass tubes was illustrated (upper panel) and quantified after crystal violet-staining (lower panel). Corresponding levels of biofilm production represent mean values and standard deviations obtained from three independent experiments. Wilcoxon-Mann-Whitney tests were performed; ** and ns referred to p<0.01 and nonsignificant difference. C. PelA (violet bars) and ExoS (royal blue bars) transcript levels were monitored using RT-qPCR and fold induction was presented in the strains PAKΔgacS::miniTn7gacSH2 (gacSH2) and PAKΔgacS::miniTn7gacSH2H→Q (gacSH2H→Q) as compared to the PAKΔgacS::miniTn7 strain (miniTn7). (D) Production of the H1-T6SS Hcp1 proteins was detected in whole cell extracts using western blot with an anti-Hcp1 polyclonal antibody. Numbers on the left side are molecular weight standards (kDa). Moderated t-tests were performed and *, **, *** and ns referred to p<0.05, p<0.01 and p<0.001 and nonsignificant difference, respectively. (E) Transcript levels of RsmY (blue bars), RsmZ (brick-red-colored bars), VgrG1 (green bars), PelA (violet bars) and ExoS (royal blue bars) were monitored using RT-qPCR. Fold induction was presented in the strains PAK, PAKΔladS, PAKgacSH1, PAKgacSH1ΔladS, PAKgacSH1→H2→ and PAKgacSH1→H2→ΔladS in order to disable autophosphorylation of the GacSH1 domain and the functionality of the GacsH2 domain, respectively. Moderated t-tests were performed and *, **, *** and ns referred to p<0.05, p<0.01 and p<0.001 and nonsignificant difference, respectively.
Fig 7In vitro transphosphorylation assays.
(A) For transphosphorylation assay between LadS or GacS variants and GacSH2 variants or HptA protein, 2 mM of LadSH1D1 or LadSH1D1D→A recombinant proteins were incubated with [γ-32P] ATP and GacSH2 (lanes 1 and 2), GacSH2H→Q (lanes 3 and 4) or HptA (lanes 5 and 6) at room temperature for 20 min (see Materials and Methods) then separated in an SDS-polyacrylamide gel in duplicate. (B) Transphosphorylation assay between the LadSH1D1D→A or GacSH1 and LadSD1 or GacsD1 domains with or without the GacSH2 domain. Two mM of LadSD1 or GacSD1 recombinant proteins were incubated with [γ-32P] ATP and LadSH1D1D→A or GacSH1 (left panel) together with the GacSH2 domain (right panel) at room temperature for 20 min. In both experiments mixtures of proteins were separated in an SDS-polyacrylamide gel in duplicate. Numbers on the left side are molecular weight standards (kDa). Locations of the recombinant proteins are indicated by arrowheads. For each experiment presented in panels A and B, one gel was detected by western blot using an anti-penta-His antibody (upper panel) while the other was autoradiographied (lower panel).
Fig 8Transphosphorylation kinetic between the LadSH1D1 or GacSH1D1 and GacSH2 domains.
Two mM of LadSH1D1 or GacSH1D1 and GacSH2 recombinant proteins were incubated with [γ-32P] ATP at room temperature. The reaction was stopped at different time points (see Materials and Methods) and the samples were separated in an SDS-polyacrylamide gel and autoradiographied.
Strains used in this study.
| Strains | Relevant characteristics | Source |
|---|---|---|
| TG1 | K-12, Δ(lac-pro) supE thi hsdD5/F' traD36 proA+B+ lacIq lacZΔM15 | Lab collection |
| DH5α | Lab collection | |
| BTH101 | F- | [ |
| Top10F’ | F’ ( | Invitrogen |
| CC118(λpir) | Host strain for pKNG101 replication, Δ( | Lab collection |
| PAK | Wild-type | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | This study |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for | This study |
| PAKΔ | PAK deletion mutant for | This study |
| PAK | PAK strain with | This study |
| PAK | PAK strain with | This study |
| PAK | PAK strain with | This study |
| PAK | PAK strain with | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAK:: | PAKstrain with empty mini Tn7 construct; GmR | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAKΔ | This study |
| PAKΔ | PAK deletion mutant for | [ |
| PAKΔ | PAK deletion mutant for D1 domain of | This study |
| PAK | Punctual chromosomal mutant H428Q of | This study |
| PAK | Punctual chromosomal mutant D718A of | This study |
| PAK | Punctual chromosomal mutant H293Q of | This study |
| PAK | Punctual chromosomal mutant H859Q of | This study |
| PAK | Punctual chromosomal mutant H293Q and H859Q of | This study |
| PAK | Punctual chromosomal mutant H293Q of | This study |
| PAK | Punctual chromosomal mutant H293Q and H859Q of | This study |
* SmR, streptomycin resistance, GmR gentamicin resistance
Plasmids used in this study.
| Plasmids | Relevant characteristics | Source |
|---|---|---|
| pLic03 | Vector containing T7 promoter with pBR322 origin of replication, KmR | [ |
| pLic03_ LadSD1 | pLic03 carrying the Nt-6his tagged LadSD1 subdomain DNA region | This study |
| pLic03_ GacSH1D1 | pLic03 carrying the Nt-6his tagged GacSH1D1 subdomain DNA region | This study |
| pLic03_ GacSH1 | pLic03 carrying the Nt-6his tagged GacSH1 subdomain DNA region | This study |
| pLic03_ GacSD1 | pLic03 carrying the Nt-6his tagged GacSD1 subdomain DNA region | This study |
| pJF_ | pJF119EH carrying the 6his tagged | This study |
| pBBRMCS3 | Broad host range plasmid, TcR | [ |
| pBBRMCS4 | Broad host range plasmid, ApR | [ |
| pBBRladS | pBBRMCS4 carrying the | [ |
| pBBR | pBBRMCS4 carrying the | This study |
| pBBR | pBBRMCS4 carrying the | This study |
| pBBR | pBBRMCS4 carrying the | This study |
| pBBR_FLAG- | pBBRMCS3 carrying the FLAG tagged | This study |
| pBBR_FLAG- | pBBRMCS3 carrying the FLAG tagged | This study |
| pBBR_FLAG- | pBBRMCS3 carrying the FLAG tagged | This study |
| PCR2.1 | TA cloning vector for PCR products, | Invitrogen |
| pCR2.1_Strep- | pCR2.1 carrying the Strep tagged | This study |
| pCR2.1_Strep-gacS | pCR2.1 carrying the Strep tagged | This study |
| pCR2.1_Strep- | pCR2.1 carrying the Strep tagged | This study |
| pCR2.1_FLAG- | pCR2.1 carrying the FLAG tagged | This study |
| pCR2.1_FLAG- | pCR2.1 carrying the FLAG tagged | This study |
| pCR2.1_FLAG- | pCR2.1 carrying the FLAG tagged | This study |
| pCR2.1 | pCR2.1 carrying the carrying the | This study |
| pCR2.1 | pCR2.1 carrying the | This study |
| pCR2.1 | pCR2.1 carrying the | This study |
| pCR2.1 | pCR2.1 carrying the | This study |
| pCR2.1intladS | pCR2.1 carrying the internal fragment | This study |
| pCR2.1intladS | pCR2.1 carrying the internal fragment | This study |
| pUC18-miniTn7 | mini-Tn | [ |
| pUC18-miniTn7- | pUC18-miniTn7 carrying the | This study |
| pUC18-miniTn7- | pUC18-miniTn7 carrying the | This study |
| pRK2013 | Tra+ Mob+ KmR | Lab collection |
| pKNG101Δ | Mutator plasmid for | This study |
| pKNG101Δ | Mutator plasmid for | This study |
| pKNG101Δ | Mutator plasmid for | [ |
| pKNG101Δ | Mutator plasmid for | [ |
| pKNG101Δ | Mutator plasmid for | [ |
| pKNG | Mutator plasmid for point mutation H428Q in | This study |
| pKNG | Mutator plasmid for point mutation D718A in | This study |
| pKNG | Mutator plasmid for point mutation H293Q in | This study |
| pKNG | Mutator plasmid for point mutation H859Q in | This study |
| pKΔS | Mutator plasmid for | [ |
| miniCTX- | Tcr
| [ |
| miniCTX- | Promoter region of | This study |
| miniCTX- | Promoter region of | This study |
| miniCTX- | Promoter region of | This study |
| miniCTX- | Promoter region of | This study |
| pUT18C | Two-hybrid plasmid, | [ |
| pUT18C- | Two-hybrid plasmid containing | This study |
| pUT18C- | Two-hybrid plasmid containing | [ |
| pUT18C- | Two-hybrid plasmid containing | [ |
| pUT18C- | Two-hybrid plasmid containing | This study |
| pKT25 | Two-hybrid plasmid, | [ |
| pKT25- | Two-hybrid plasmid containing | This study |
| pKT25- | Two-hybrid plasmid containing | [ |
| pKT25- | Two-hybrid plasmid containing | [ |
| pKT25- | Two-hybrid plasmid containing | [ |
| pKT25- | Two-hybrid plasmid containing | [ |
| pKT25- | Two-hybrid plasmid containing | [ |
| pKT25- | Two-hybrid plasmid containing | This study |
| pKT25- | Two-hybrid plasmid containing | This study |
| pKT25- | Two-hybrid plasmid containing | This study |
| pKT25- | Two-hybrid plasmid containing | This study |
| pKT25- | Two-hybrid plasmid containing | This study |
* SmR, streptomycin resistance, GmR gentamicin resistance, TCR tetracyclin resistance, ApR ampicillin, KmR Kanamycin